Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | CCL2 | P13500 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5698322 | 0.74 | HTR2A (0.44) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL29723413 | 0.73 | HTR2A (0.40) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Fluoride Ion SCHEMBL5183865 | 0.73 | HTR2A (0.40) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL3761120 | 0.73 | HTR2A (0.40) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| SCHEMBL6233907 | 0.72 | HTR2A (0.43) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| SCHEMBL31046607 | 0.72 | HTR2A (0.43) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL6909925 | 0.71 | HTR2A (0.39) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| Hydrochloric Acid SCHEMBL16758127 | 0.71 | HTR2A (0.39) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| SCHEMBL23071395 | 0.70 | HTR2A (0.41) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 | |
| SCHEMBL4927002 | 0.70 | HTR2A (0.41) | HTR2AHTR6SIGMAR1KDM4ECYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | ARLANXEO NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | disclosed |
| CN-115279804-B | Ethylene copolymers and catalyst mixtures for making ethylene copolymers | 阿朗新科荷兰有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230331884-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | ARLANXEO NETHERLANDS B.V. (NL) | 2023-10-19 | — | — | US | disclosed |
| US-11767376-B2 | Catalyst mixture | ARLANXEO NETHERLANDS B.V. (NL) | 2023-09-26 | — | — | US | disclosed |
| CN-112703208-B | Catalyst mixture | 阿朗新科荷兰有限公司 | 2023-02-24 | — | — | CN | disclosed |
| CN-115279804-A | Ethylene copolymers and catalyst mixtures for the production of ethylene copolymers | 阿朗新科荷兰有限公司 | 2022-11-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | EEF1D, COG7, CCND1 | HTR2A 4461/4885HTR6 4091/4885SIGMAR1 913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.